Windlas Biotech Limited (NSE:WINDLAS)

India · Delayed Price · Currency is INR

816.00

+8.35 (1.03%)

Jun 19, 2026, 3:30 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018
Pharmaceuticals	9.04B	7.60B	6.31B	5.13B	4.66B
Pharmaceuticals Growth	18.98%	20.43%	22.97%	10.12%	8.96%
Total	9.04B	7.60B	6.31B	5.13B	4.66B
Total Growth	18.98%	20.43%	22.97%	10.12%	8.96%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018
India	7.22B	6.01B	4.91B	4.42B
India Growth	20.12%	22.57%	10.92%	8.52%
outside India	326.32M	273.91M	198.43M	209.35M
outside India Growth	19.13%	38.04%	-5.22%	10.21%
Total	7.55B	6.29B	5.11B	4.63B
Total Growth	20.07%	23.17%	10.19%	8.59%